Despite a high clinical prevalence rate of Parkinson's disease in India, autopsy studies have not been reported in the country, till date. Two autopsied cases clinically diagnosed as Parkinson's disease in our Institute were neuropathologically evaluated. Clinically, they presented with the classical features typical of the disease like tremors, rigidity, mask-like facies and bradykinesia. A distinct loss of melanin-containing neurons of the substantia-nigra in the midbrain and in the locus ceruleus was observed. Characteristic single and multiple intraneuronal Lewy bodies were seen in the substantia nigra, locus ceruleus and occasionally in the basal nucleus of Meynert, posterior thalamic nucleus and neurons of occulomotor nucleus. Immunohistochemically, these classical Lewy bodies were ubiquitin in positive, showing two morphological forms: one, as a homogenous dense body and the other, as a peripheral dense staining with a central lucent zone. These bodies failed to react with the neurofilament antibodies. The neuronal loss in the midbrain was associated with gliosis, confirmed by PTAH and GFAP immunostaining. There were no features of dementia, either clinically or neuropathologically in both cases.
Download full-text PDF |
Source |
---|
Acta Neurol Belg
January 2025
Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100050, China.
Objective: This cross-sectional study aims to assess the levels of stigma among patients with Parkinson's disease (PD) and identify the demographic and clinical factors influencing both internal and external stigma.
Materials And Methods: A total of 200 patients diagnosed with PD were recruited from Beijing Tiantan Hospital between June 2023 and June 2024 using convenience sampling. Data were collected through face-to-face interviews, including demographic information, disease severity assessed via the Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS), and stigma levels measured using the 24-item Stigma Scale for Chronic Illness (SSCI).
Handb Clin Neurol
January 2025
Massachusetts General Hospital, Boston, MA, United States.
Irregular sleep-wake rhythm disorder (ISWRD) is an intrinsic circadian rhythm disorder caused by loss of the brain's circadian regulation, through changes of the input and/or output to the suprachiasmatic nucleus (SCN), or of the SCN itself. Although there are limited prevalence data for this rare disease, ISWRD is associated with neurodegenerative disorders, including the Alzheimer disease (AD) and the Parkinson disease (PD), which will become increasingly prevalent in an aging population. It additionally presents in childhood developmental disorders, psychiatric disorders, and traumatic brain injury (TBI).
View Article and Find Full Text PDFThis study investigated two cases. Case 1 involves a 53-year-old man who suffered from sleep apnea syndrome at age 48. Moreover, he was involved in a rear-end collision while driving and was admitted to the hospital at age.
View Article and Find Full Text PDFBiosci Trends
January 2025
Department of Geriatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Growth and differentiation factor 15 (GDF15), a member of the transforming growth factor-βsuperfamily, is considered a stress response factor and has garnered increasing attention in recent years due to its roles in neurological diseases. Although many studies have suggested that GDF15 expression is elevated in patients with neurodegenerative diseases (NDDs), glioma, and ischemic stroke, the effects of increased GDF15 expression and the potential underlying mechanisms remain unclear. Notably, many experimental studies have shown the multidimensional beneficial effects of GDF15 on NDDs, and GDF15 overexpression is able to rescue NDD-associated pathological changes and phenotypes.
View Article and Find Full Text PDFBiosci Trends
January 2025
School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China.
Parkinson's disease (PD) is a progressive disease that requires effective staging management. The role of intestinal microbiota in PD has been studied, but its changes at different stages are not clear. In this study, meta- analysis, bioinformatics analysis and in vivo simulation were used to explore the intestinal microbiota distribution of PD patients and models at different stages.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!